| ASSET | MONTH | % RETURN |
|---|---|---|
Nxu (NXU) | September 2022 | 1,590,336.59% |
FingerMotion (FNGR) | September 2022 | 262.37% |
Heartbeam (BEAT) | September 2022 | 222.31% |
Avenue Therapeutics (ATXI) | September 2022 | 205.45% |
Akero Therapeutics (AKRO) | September 2022 | 183.99% |
Immuneering (IMRX) | September 2022 | 179.69% |
Spero Therapeutics (SPRO) | September 2022 | 143.9% |
Sobr Safe (SOBR) | September 2022 | 139.29% |
Prothena (PRTA) | September 2022 | 122.66% |
Enliven Therapeutics (ELVN) | September 2022 | 96.55% |
LAVA Therapeutics (LVTX) | September 2022 | 86.53% |
NRx Pharmaceuticals (NRXPW) | September 2022 | 80% |
Pulse Biosciences (PLSE) | September 2022 | 79.69% |
Forafric Global PLC Warrants (AFRIW) | September 2022 | 79.04% |
Jowell Global (JWEL) | September 2022 | 78.57% |
Acumen Pharmaceuticals (ABOS) | September 2022 | 78.47% |
X4 Pharmaceuticals (XFOR) | September 2022 | 76.29% |
Pasithea Therapeutics Corp Warrant (KTTAW) | September 2022 | 73.71% |
Heartbeam Inc Warrant (BEATW) | September 2022 | 73.24% |
Vertical Aerospace (EVTL) | September 2022 | 68.65% |
Ventyx Biosciences (VTYX) | September 2022 | 67.43% |
Cassava Sciences (SAVA) | September 2022 | 63.62% |
Stabilis Solutions (SLNG) | September 2022 | 62.95% |
InnovAge (INNV) | September 2022 | 61.98% |
FAT Brands (FATBW) | September 2022 | 58.28% |
